Title: The association between jaundice and poorly differentiated pancreatic neuroendocrine
neoplasms (Ki67 index > 55.0%)
Version: 2 Date: 13 Nov 2023
Reviewer's report:
The revised manuscript titled "The association between jaundice and poorly differentiated
pancreatic neuroendocrine neoplasms (Ki67 index > 55.0%)" has shown considerable
improvement from its previous version.
While the findings are significant, still the manuscript would benefit from a more detailed
discussion on how these findings fit into the broader landscape of PNEN research and clinical
management, potentially comparing and contrasting with other predictive markers (such as NSE
and Chromogranin A, see also PMID: 37658563, PMID: 25428270 and PMID: 21945100).
Please add this points to the discussion
Title: The association between jaundice and poorly differentiated pancreatic neuroendocrine
neoplasms (Ki67 index > 55.0%)
Version: 2 Date: 13 Nov 2023
Reviewer's report:
The revised manuscript titled "The association between jaundice and poorly differentiated
pancreatic neuroendocrine neoplasms (Ki67 index > 55.0%)" has shown considerable
improvement from its previous version.
While the findings are significant, still the manuscript would benefit from a more detailed
discussion on how these findings fit into the broader landscape of PNEN research and clinical
management, potentially comparing and contrasting with other predictive markers (such as NSE
and Chromogranin A, see also PMID: 37658563, PMID: 25428270 and PMID: 21945100).
Please add this points to the discussion
Please review this paper.
user
Title: The association between jaundice and poorly differentiated pancreatic neuroendocrine
neoplasms (Ki67 index > 55.0%)
Version: 2 Date: 13 Nov 2023
Reviewer's report:
The revised manuscript titled "The association between jaundice and poorly differentiated
pancreatic neuroendocrine neoplasms (Ki67 index > 55.0%)" has shown considerable
improvement from its previous version.
While the findings are significant, still the manuscript would benefit from a more detailed
discussion on how these findings fit into the broader landscape of PNEN research and clinical
management, potentially comparing and contrasting with other predictive markers (such as NSE
and Chromogranin A, see also PMID: 37658563, PMID: 25428270 and PMID: 21945100).
Please add this points to the discussion
assistant